The 480 Biomedical Stanza scaffold technology combines biocompatible materials with innovative engineering for optimal balance of radial force, flexibility and bioresorbability. The firm's proprietary scaffold is also ideal for controlled delivery of drug for up to several months.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/12/13 | $18,000,000 | |||
| 06/01/15 | $10,500,000 |
Intersouth Partners North Bridge Venture Partners Polaris Partners | undisclosed |
